Biotechnology Assets, S.A. (BME:BST)

Market Cap	14.71M -42.1%
Revenue (ttm)	3.43M -4.9%
Net Income	-1.92M
EPS	n/a
Shares Out	75.07M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	37,400
Open	0.1935
Previous Close	0.2040
Day's Range	0.1935 - 0.1995
52-Week Range	0.1760 - 0.3700
Beta	2.10
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About Biotechnology Assets

Biotechnology Assets, S.A. develops and markets biotechnological assets for application in the biopharmaceutical, agrochemical, cosmetic, veterinary, and chemical industries in Spain and internationally. It offers SPLITTERA, a solution for site-specific conjugation of proteins; Click Car for Split-CARs universal connectors; VACC-ZERA, a tool to generate recombinant proteins in microparticles; and CLICK’N CUT for tag-less protein purification. The company is based in Cádiz, Spain.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1954
• Employees: 26
• Stock Exchange: Madrid Stock Exchange
• Ticker Symbol: BST

Financial Performance

In 2025, Biotechnology Assets's revenue was 3.43 million, a decrease of -4.88% compared to the previous year's 3.61 million. Losses were -1.92 million, -34.32% less than in 2024.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Oct 27, 2026

Data Sources Report a data error